Core-binding factor β interacts with Runx2 and is required for skeletal development
- 18 November 2002
- journal article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 32 (4), 633-638
- https://doi.org/10.1038/ng1015
Abstract
Core-binding factor (CBF, also called polyomavirus enhancer binding protein 2 (PEBP2B)) is associated with an inversion of chromosome 16 and is associated with acute myeloid leukemia in humans1. CBF forms a heterodimer with RUNX1 (runt-related transcription factor 1), which has a DNA binding domain homologous to the pair-rule protein runt in Drosophila melanogaster. Both RUNX1 and CBF are essential for hematopoiesis2, 3, 4, 5, 6. Haploinsufficiency of another runt-related protein, RUNX2 (also called CBFA1), causes cleidocranial dysplasia in humans7 and is essential in skeletal development by regulating osteoblast differentiation and chondrocyte maturation8, 9, 10, 11, 12, 13, 14, 15. Mice deficient in Cbfb (Cbfb-/-) die at midgestation4, 5, 6, so the function of Cbf in skeletal development has yet to be ascertained. To investigate this issue, we rescued hematopoiesis of Cbfb-/- mice by introducing Cbfb using the Gata1 promoter. The rescued Cbfb-/- mice recapitulated fetal liver hematopoiesis in erythroid and megakaryocytic lineages and survived until birth, but showed severely delayed bone formation. Although mesenchymal cells differentiated into immature osteoblasts, intramembranous bones were poorly formed. The maturation of chondrocytes into hypertrophic cells was markedly delayed, and no endochondral bones were formed. Electrophoretic mobility shift assays and reporter assays showed that Cbf was necessary for the efficient DNA binding of Runx2 and for Runx2-dependent transcriptional activation. These findings indicate that Cbf is required for the function of Runx2 in skeletal development.Keywords
This publication has 30 references indexed in Scilit:
- Cbfβ interacts with Runx2 and has a critical role in bone developmentNature Genetics, 2002
- The core-binding factor β subunit is required for bone formation and hematopoietic maturationNature Genetics, 2002
- Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in ChondrocytesThe Journal of cell biology, 2001
- Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβCell, 2001
- Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12Molecular and Cellular Biology, 2000
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000
- Excessive Extramedullary Hematopoiesis in Cbfa1-Deficient Mice with a Congenital Lack of Bone MarrowBiochemical and Biophysical Research Communications, 1999
- Differentiation dependent expression and distinct subcellular localization of the protooncogene product, PEBP2β/CBFβ, in muscle developmentOncogene, 1997
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996
- Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid LeukemiaScience, 1993